451
Participants
Start Date
March 24, 2022
Primary Completion Date
January 30, 2024
Study Completion Date
January 30, 2024
Posoleucel (ALVR105)
Administered as 2-4 milliliter infusion, visually identical to placebo
Placebo
Administered as 2-4 milliliter infusion, visually identical to Posoleucel (ALVR105)
Columbia University, New York
Weill Cornell Medical College, New York
Stony Brook University Hospital Cancer Center, Stony Brook
Roswell Park Cancer Institute, Buffalo
University of Pennsylvania, Philadelphia
Childrens National Health System, Washington D.C.
University of Maryland, Baltimore
University of Virginia, Charlottesville
Virginia Commonwealth University, Richmond
Carolinas Medical Center/Levine, Charlotte
Northside Hospital, Atlanta
University of Florida (UF) - Gainesville, Gainesville
Moffitt Cancer Center, Tampa
University of Alabama at Birmingham Children's of Alabama, Birmingham
Nationwide Children's Hospital, Columbus
Indiana University Hospital Simon Comprehensive Cancer Center, Indianapolis
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
University of Minnesota, Minneapolis
Loyola University Medical Center, Maywood
Washington University School of Medicine, St Louis
Children's Mercy Hospital, Kansas City
University of Kansas Hospital, Kansas City
Children's Medical Center Dallas, Dallas
University of Colorado Hospital, Aurora
University of Utah/Primary Childrens Hospital, Salt Lake City
Honor Health Research Institute, Scottsdale
University of California, Los Angeles (UCLA), Los Angeles
City of Hope, Duarte
University of California San Francisco - Benioff Children's Hospital, San Francisco
Stanford University, Palo Alto
Oregon Health & Science University, Portland
Fred Hutchinson Cancer Research Center, Seattle
Yale University School of Medicine - Yale Cancer Center, New Haven
Dana-Farber Cancer Institute, Boston
Hackensack University Medical Center, Hackensack
Royal Adelaide Hospital, Adelaide
Austin Health, Heidelberg
Royal Brisbane and Women's Hospital, Herston
Royal Melbourne Hospital, Parkville
Queensland Children's Hospital, South Brisbane
Westmead Hospital, Westmead
A.Z. Sint-Jan Brugge Oostende AV, Bruges
Institut Jules Bordet and the Childrens Hospital, Brussels
University Hospital Gasthuisberg and Leuven, Leuven
Alberta Children's Hospital, Calgary
Cellular Therapy Program - CHU Sainte-Justine (McGill), Montreal
Hopital Maisonneve Rosemont, Montreal
The Hospital for Sick Children Blood & Marrow Transplant / Cellular Therapy Program, Toronto
UHN Blood and Marrow Transplant (BMT) Program (Princess Margaret) Cancer Center, Toronto
Leukemia/ BMT Program of British Columbia - Vancouver General Hospital, Vancouver
Centre Hospitalier Regional Universitaire de Lille, Lille
CHU de Nantes, Nantes
AP-HP Hopital Saint-Louis, Paris
Hopital Saint Antoine, Paris
Hopital Universitaire Robert Debre, Paris
Centre Hospitalier Lyon Sud, Pierre-Bénite
IUCT-Oncopole, Toulouse
Azienda Ospedaliero-Universitaria Careggi, Florence
Ospedale San Raffaele, Milan
Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia
IRCSS Ospedale Pediatrico Bambino Gesu, Roma
University of Sacred Heart Policlinico A. Gemelli, Rome
Humanitas Cancer Center, Rozzano
Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Verona
Pusan National University Hospital, Busan
Chonnam National University Hwasun Hospital, Hwasun
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Seoul St. Mary's Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Institut Catala d'Oncologia, Barcelona
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Regional Universitario de Malaga, Málaga
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Acibadem Adana Hospital, Adana
Baskent Adana Hospital, Adana
Ankara Onkoloji Egitim Ve Arastirma Hastanesi, Ankara
Ankara University Hospital, Ankara
Gazi University Medical Faculty Hospital, Ankara
Medical Park Hospital, Antalya
Ege University Medical Faculty, Izmir
Anadolu Medical Center Hospital, Kocaeli
Inonu University Turgut Özal Medical Centre, Malatya
Bristol Haematology and Oncology Centre, Bristol
University Hospitals Bristol - Bristol Hospital for Children, Bristol
Addenbrooke's Hospital, Cambridge
Queen Elizabeth University Hospital - Glasgow, Glasgow
Great Ormond Street Hospital for Children, London
Lead Sponsor
AlloVir
INDUSTRY